These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 8751855

  • 1. Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2.
    Rebbeck TR, Couch FJ, Kant J, Calzone K, DeShano M, Peng Y, Chen K, Garber JE, Weber BL.
    Am J Hum Genet; 1996 Sep; 59(3):547-53. PubMed ID: 8751855
    [Abstract] [Full Text] [Related]

  • 2. Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage.
    Marcus JN, Watson P, Page DL, Narod SA, Lenoir GM, Tonin P, Linder-Stephenson L, Salerno G, Conway TA, Lynch HT.
    Cancer; 1996 Feb 15; 77(4):697-709. PubMed ID: 8616762
    [Abstract] [Full Text] [Related]

  • 3. BRCA1 and BRCA2 in breast cancer.
    Yang X, Lippman ME.
    Breast Cancer Res Treat; 1999 Mar 15; 54(1):1-10. PubMed ID: 10369075
    [Abstract] [Full Text] [Related]

  • 4. Breast cancer susceptibility genes. BRCA1 and BRCA2.
    Brody LC, Biesecker BB.
    Medicine (Baltimore); 1998 May 15; 77(3):208-26. PubMed ID: 9653432
    [Abstract] [Full Text] [Related]

  • 5. Confirmation of susceptibility locus on chromosome 13 in Australian breast cancer families.
    Grimmond SM, Palmer JM, Walters MK, Scott C, Nancarrow DJ, Teh BT, Elmes C, Pyke C, Khoo SK, Bennett I, Wetzig N, Hayward NK.
    Hum Genet; 1996 Jul 15; 98(1):80-5. PubMed ID: 8682513
    [Abstract] [Full Text] [Related]

  • 6. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.
    Martin AM, Blackwood MA, Antin-Ozerkis D, Shih HA, Calzone K, Colligon TA, Seal S, Collins N, Stratton MR, Weber BL, Nathanson KL.
    J Clin Oncol; 2001 Apr 15; 19(8):2247-53. PubMed ID: 11304778
    [Abstract] [Full Text] [Related]

  • 7. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
    Machácková E, Foretová L, Navrátilová M, Valík D, Claes K, Messiaen L.
    Cas Lek Cesk; 2000 Oct 11; 139(20):635-7. PubMed ID: 11192759
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.
    Vehmanen P, Friedman LS, Eerola H, McClure M, Ward B, Sarantaus L, Kainu T, Syrjäkoski K, Pyrhönen S, Kallioniemi OP, Muhonen T, Luce M, Frank TS, Nevanlinna H.
    Hum Mol Genet; 1997 Dec 11; 6(13):2309-15. PubMed ID: 9361038
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes?
    Serova OM, Mazoyer S, Puget N, Dubois V, Tonin P, Shugart YY, Goldgar D, Narod SA, Lynch HT, Lenoir GM.
    Am J Hum Genet; 1997 Mar 11; 60(3):486-95. PubMed ID: 9042907
    [Abstract] [Full Text] [Related]

  • 13. Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.
    Johannsson O, Ostermeyer EA, Håkansson S, Friedman LS, Johansson U, Sellberg G, Brøndum-Nielsen K, Sele V, Olsson H, King MC, Borg A.
    Am J Hum Genet; 1996 Mar 11; 58(3):441-50. PubMed ID: 8644702
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Linkage analysis of 26 Canadian breast and breast-ovarian cancer families.
    Tonin P, Moslehi R, Green R, Rosen B, Cole D, Boyd N, Cutler C, Margolese R, Carter R, McGillivray B.
    Hum Genet; 1995 May 11; 95(5):545-50. PubMed ID: 7759076
    [Abstract] [Full Text] [Related]

  • 16. A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland.
    Arason A, Jonasdottir A, Barkardottir RB, Bergthorsson JT, Teare MD, Easton DF, Egilsson V.
    J Med Genet; 1998 Jun 11; 35(6):446-9. PubMed ID: 9643283
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus.
    Kainu T, Juo SH, Desper R, Schaffer AA, Gillanders E, Rozenblum E, Freas-Lutz D, Weaver D, Stephan D, Bailey-Wilson J, Kallioniemi OP, Tirkkonen M, Syrjäkoski K, Kuukasjärvi T, Koivisto P, Karhu R, Holli K, Arason A, Johannesdottir G, Bergthorsson JT, Johannsdottir H, Egilsson V, Barkardottir RB, Johannsson O, Haraldsson K, Sandberg T, Holmberg E, Grönberg H, Olsson H, Borg A, Vehmanen P, Eerola H, Heikkila P, Pyrhönen S, Nevanlinna H.
    Proc Natl Acad Sci U S A; 2000 Aug 15; 97(17):9603-8. PubMed ID: 10944226
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland.
    van Der Looij M, Wysocka B, Brozek I, Jassem J, Limon J, Olah E.
    Hum Mutat; 2000 May 15; 15(5):480-1. PubMed ID: 10790213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.